Top Markets
#1 Official Trump Official Trump +51.60%
#2 Mubarak Mubarak +28.48%
#3 Melania Meme Melania Meme +26.88%
#4 Movement Movement +26.70%
#5 Zama Zama +26.06%
#6 EXOD EXOD +22.08%
#7 Pearl Pearl +21.29%
#8 Wrapped POL Wrapped POL +18.85%
#9 POL (ex-MATIC) POL (ex-MATIC) +18.51%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +16.86%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
EXoZymes, Inc. EXoZymes, Inc.

EXoZymes, Inc.

EXOZ
Rank in Stocks #23841
eXoZymes, Inc. operates as a development stage biotechnology company. It... eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Share Price
$7.38
Last synced: 2026-08-21
Market Cap
$68.45M
Change (1 day)
4.76%
Change (1 year)
-20.78%
Country
US
Trade EXoZymes, Inc. (EXOZ)

Category

Healthcare
Revenue for EXoZymes, Inc. (EXOZ)
Revenue in Aug 2026 TTM: 0
According to EXoZymes, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for EXoZymes, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH